Global Retinal Detachment Disorder Market Size, Share, and COVID-19 Impact Analysis, By Type (Rhegmatogenous Retinal Detachment, Tractional Retinal Detachment, Exudative Retinal Detachment), By Treatment (Photocoagulation [Laser Surgery], Cryopexy [Freezing], Pneumatic Retinopexy, Scleral Buckling and Vitrectomy), By End Users (Hospitals, Clinics, Speciality Centers, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 - 2030
Industry: HealthcareGlobal Retinal Detachment Disorder Market Insights Forecasts to 2030
- The Global Retinal Detachment Disorder Market Size was valued at USD 1.7 Billion in 2021.
- The Market is Growing at a CAGR of 8.3% from 2022 to 2030.
- The Worldwide Retinal Detachment Disorder Market size is expected to reach USD 3.5 Billion by 2030.
- Asia Pacific is expected to grow the fastest during the forecast period.
Get more details on this report -
The Global Retinal Detachment Disorder Market Size is expected to reach USD 3.5 Billion by 2030, at a CAGR of 8.3% during the forecast period 2022 to 2030. Due to the growing elderly population and the advanced infrastructure, Europe is expected to hold the second-largest position in the retinal detachment market.
Market Overview
Retinal detachment disorder is When the retina, the delicate layer of nerve tissue that lines the back of the eye and moves away from its normal position, is a condition known as retinal detachment. The layer of blood vessels that supply oxygen and nourishment to the retinal cells is separated from them by retinal detachment. The risk of permanent vision loss in the affected eye increases as retinal detachment goes untreated for a longer period. Retinal detachment can occur in three different ways, including rhegmatogenous, tractional, and exudative. A thin layer of tissue (the retina) in the back of the eye rips away from its usual position in a condition known as retinal detachment, which is a serious condition of the eye. Due to this disorder, the layer of blood vessels that nourishes and oxygenates the eyes has been separated from the retinal cells. According to WHO, 180 million people globally have vision problems as of September 2021, and 40–45 million individuals were blind. According to the same source, about 80% of blindness worldwide is preventable, meaning the disease can be treated if the necessary information and medical measures are given at the appropriate time or arise from certain situations that can be avoided. Retinal breaks, tears, or holes are the most common causes of retinal detachments. Depending on how much of the retina has detached, retinal detachment can result in either partial or complete blindness.
Report Coverage
This research report categorizes the global retinal detachment disorder market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global retinal detachment disorder market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the global retinal detachment disorder market. Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market.
Global Retinal Detachment Disorder Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2021 |
Market Size in 2021: | USD 1.7 Billion |
Forecast Period: | 2021-2030 |
Forecast Period CAGR 2021-2030 : | 8.3% |
2030 Value Projection: | USD 3.5 Billion |
Historical Data for: | 2017-2020 |
No. of Pages: | 200 |
Tables, Charts & Figures: | 100 |
Segments covered: | By Type, By Treatment, By End Users, By Region, COVID-19 Impact Analysis |
Companies covered:: | Carl Zeiss Meditec, Centervue SpA, Lab Pensacola, Eyenuk Inc., Imagine Eyes, HealPros, LLC., NEUROVISION IMAGING, LLC., Optos, Peek Vision Ltd. |
Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The major driving factors for the global retinal detachment disorder market growth include the Growing technical improvements and an increase in retinal detachment instances that are expected to drive the market growth. The increase in the number of eye surgeries is also expected to drive market growth. Furthermore, Factors such as an aging population and an increase in the prevalence of diabetic retinopathy and other eye diseases among the population are driving the market growth. Moreover, Eye conditions such as cataracts, glaucoma, dry eye disease, and others are becoming more aware throughout the global population due to these conditions increases the demand for eye therapies, which is projected to accelerate market expansion over the forecast period.
Restraining Factors
The market growth of retinal detachment disorder is restricted due to the high price of retinal surgery instruments. Also, the limited availability of skilled professional’s restraints the growth. Moreover, the lack of awareness in underdeveloped regions is expected to hamper market growth.
Market Segmentation
In 2021, the rhegmatogenous segment is holding the largest market share over the forecast period.
Based on the types, the global retinal detachment disorder market is segmented into rhegmatogenous retinal detachment, tractional retinal detachment, and exudative retinal detachment. Among these, the rhegmatogenous segment is holding the market share over the forecast period due to the incidence rising with the elderly population of rhegmatogenous retinal detachment. According to the United Nations' 2017 "World Aging Population" research the number of RRD patients is anticipated to increase as the world's elderly population increases and early disorder detection helps patients to avoid financial hardship as a result. Rhegmatogenous retinal detachment (RRD), a disorder that may damage vision, is estimated to impact 10 to 18 people out of every 100,000 people in the United States annually.
In 2021, the hospital segment is leading the market over the forecast period.
Based on the end users, the global retinal detachment market is classified into hospitals, clinics, specialty centers, and others. Among these segments, the hospital segment held the largest market share due to various treatments available for retinal detachment including surgery, laser treatment, and cryotherapy (freezing) in the hospital segment which may grow the market share during the forecast period. Moreover, the increasing number of patients who are suffering from this disorder, receive care in hospitals with modern infrastructure and sufficient resources for their condition.
Global Retinal Detachment Disorder Market, By Treatment
The retinal detachment market, by treatment, has been bifurcated into different segments, such as photocoagulation (laser surgery), cryopexy (freezing), pneumatic retinopexy, scleral buckling, and vitrectomy.
Regional Segment Analysis of the retinal detachment disorder market
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Rest of APAC)
- South America (Brazil and the Rest of South America)
- The Middle East and Africa (UAE, South Africa, Rest of MEA)
North America is dominating the largest market share of 41.3% during the forecast period
Get more details on this report -
North America accounts for the largest market share during the forecast period, owing to the increasing patient population suffering from retinal detachment and growing awareness regarding the condition in this region. Furthermore, a strong healthcare infrastructure with access to cutting-edge technologies is present in this region and is dominating the market during the forecast period. The Asia Pacific market is expected to be the fastest-growing market during the forecast period due to the rising geriatric population and effective reimbursement policies. Also, the rapidly developing economies in this region are expected to grow the fastest market over the forecast period.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global retinal detachment disorder market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Carl Zeiss Meditec
- Centervue SpA
- Lab Pensacola
- Eyenuk Inc.
- Imagine Eyes
- HealPros, LLC.
- NEUROVISION IMAGING, LLC.
- Optos
- Peek Vision Ltd.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Developments
- December 2022: In Vashi, Navi Mumbai, ASG Eye Hospitals opened a brand-new specialist eye hospital for the treatment of simple to the most complex eye disorder. The hospital provides scleral buckling operations, vitrectomy treatments, and pneumatic retinopexy procedures for retinal detachment.
- April 2022: To further improve its position in the market, Carl Zeiss Meditec purchased two manufacturers of surgical equipment, such as Kogent Surgical, LLC, and Katalyst Surgical, LLC.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the Global Detachment Disorder Market based on the below-mentioned segments:
Global Retinal Detachment Disorder Market, By Types
- Rhegmatogenous Retinal Detachment
- Tractional Retinal Detachment
- Exudative Retinal Detachment
Global Retinal Detachment Disorder Market, By Treatment
- Photocoagulation [Laser Surgery]
- Cryopexy [Freezing]
- Pneumatic Retinopexy
- Scleral Buckling
- Vitrectomy
Global Retinal Detachment Disorder Market, By End Users
- Hospitals
- Clinics
- Speciality Centers
- Others
Retinal Detachment Disorder Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Uk
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of Middle East & Africa
Need help to buy this report?